EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Resistance Trends in Hidradenitis Suppurativa Lesions

Dimitra Koumaki iD, Georgios Evangelou, Sofia Maraki, Evangelia Rovithi, Danae Petrou, Erato Solia Apokidou, Stamatios Gregoriou iD, Vasiliki Koumaki, Petros Ioannou iD, Kyriaki Zografaki iD, Aikaterini Doxastaki, Alexander Katoulis iD und 4 weitere

Journal of Clinical Medicine · 20.07.2024 · 13 (14) · 4246

DOI: 10.3390/jcm13144246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.07.2024. Verfasst von Dimitra Koumaki und 15 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, University Hospital of Heraklion, Heraklion, 711 10 Crete, Greece. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Antibiotic (AB) therapy is the first step in managing hidradenitis suppurativa (HS). Knowledge of the local patterns of antimicrobial resistance is paramount for the appropriate selection of antimicrobials. This study aimed to assess the occurrence of antibiotic resistance in patients with HS.

Methods

A cross-sectional study was conducted on 103 patients with HS seen at the Dermatology Department at the University Hospital of Heraklion, Heraklion, Crete, Greece, from January 2019 to December 2023, who were not on any antibiotics in the last three months.

Results

A total of 103 patients with HS participated in this study. Purulent material from 139 skin lesions of these patients was swabbed, and 79.86% (111/139) tested positive for bacteria. Gram-positive isolates accounted for 73%, whereas Gram-negative isolates comprised 27%. Among the isolates, 85.1% were aerobes, and 14.9% were anaerobic. The most common bacterial families isolated were Staphylococcaceae (48.27%), Enterobacteriaceae (14.94%), and Streptococcaceae (6.89%). The antibiogram profiles of bacterial cultures revealed a 57.1% resistance to levofloxacin and a 53.3% resistance to penicillin in Staphylococcus lugdunensis, whereas Staphylococcus aureus showed a 76.9% resistance to penicillin and a 58.3% resistance to fusidic acid. High resistance rates of 63.5% for tigecycline, 63.3% for ampicillin, and 40.5% for colistin were observed for Gram-negative isolates. Resistances of 62.5%, 61.5%, and 53.8% to erythromycin, clindamycin, and penicillin, respectively, were observed in the anaerobes.

Conclusions

Patients with HS displayed considerable resistance to bacterial proliferation. The revised therapeutic guidelines for HS should incorporate the latest insights into bacterial antibiotic resistance.

Schlagwörter

Stichwörter der Autor:innen

Staphylococcus aureusStaphylococcus lugdunensisantibiotic resistancebacteriahidradenitis suppurativapenicillin

Autor:innen und Institutionen

  • Dermatology Department, University Hospital of Heraklion, Heraklion, 711 10 Crete, Greece.
  • Department of Clinical Microbiology, University Hospital of Heraklion, Heraklion, 711 10 Crete, Greece.
  • Department of Internal Medicine, Agios Nikolaos General Hospital, Knosou 4, Ag. Nikolaos, 721 00 Crete, Greece.
  • 1st Department of Dermatology and Venereology, Medical School of Athens, National and Kapodistrian University of Athens, Andreas Sygros Hospital, I. Dragoumi 5, 161 21 Athens, Greece.
  • Department of Medical Microbiology, Medical School of Athens, National and Kapodistrian University of Athens, 75 Mikras Asias Str., Goudi, 115 27 Athens, Greece.
  • Department of Internal Medicine, University Hospital of Heraklion, Heraklion, 711 10 Crete, Greece.

ORCID-Profile: Dimitra Koumaki, Stamatios Gregoriou, Petros Ioannou, Kyriaki Zografaki, Alexander Katoulis

Zitieren

APA

Koumaki, D., Evangelou, G., Maraki, S., Rovithi, E., Petrou, D., Apokidou, E. S., Gregoriou, S., Koumaki, V., Ioannou, P., Zografaki, K., Doxastaki, A., Katoulis, A., Papadopoulou, K., Stafylaki, D., Mavromanolaki, V. E., & Krasagakis, K. (2024). Antimicrobial Resistance Trends in Hidradenitis Suppurativa Lesions. Journal of Clinical Medicine, 13(14), 4246. https://doi.org/10.3390/jcm13144246

Vancouver

Koumaki D, Evangelou G, Maraki S, Rovithi E, Petrou D, Apokidou ES, et al. Antimicrobial Resistance Trends in Hidradenitis Suppurativa Lesions. Journal of Clinical Medicine. 2024;13(14):4246. doi:10.3390/jcm13144246

BibTeX
@article{Koumaki2024,
  author = {Koumaki, Dimitra and Evangelou, Georgios and Maraki, Sofia and Rovithi, Evangelia and Petrou, Danae and Apokidou, Erato Solia and Gregoriou, Stamatios and Koumaki, Vasiliki and Ioannou, Petros and Zografaki, Kyriaki and Doxastaki, Aikaterini and Katoulis, Alexander and Papadopoulou, Kalliopi and Stafylaki, Dimitra and Mavromanolaki, Viktoria Eirini and Krasagakis, Konstantinos},
  title = {Antimicrobial Resistance Trends in Hidradenitis Suppurativa Lesions},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {4246},
  doi = {10.3390/jcm13144246}
}
Kostenlos starten →